Sectors - Clinical Trials Arena https://www.clinicaltrialsarena.com/sector/clinical/ Hard data and deep insights on clinical trials strategy & operations Tue, 31 Oct 2023 16:09:58 +0000 en-US hourly 1 https://wordpress.org/?v=6.6.2 https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2022/01/cropped-Clinical-Trials-Arena-32x32.png Sectors - Clinical Trials Arena https://www.clinicaltrialsarena.com/sector/clinical/ 32 32 M&A market performance suffered in Q3 2023 https://www.clinicaltrialsarena.com/analyst-comment/ma-market-performance-suffered-in-q3-2023/ Tue, 31 Oct 2023 15:58:27 +0000 https://www.clinicaltrialsarena.com/?p=190510 The third quarter of 2023 saw a slight fall in deal activity after the recovery in the global M&A market in the second quarter.

The post M&A market performance suffered in Q3 2023 appeared first on Clinical Trials Arena.

]]> The post M&A market performance suffered in Q3 2023 appeared first on Clinical Trials Arena.

]]> University of Queensland to begin trial of molecular clamp vaccine https://www.clinicaltrialsarena.com/news/university-of-queensland-vaccine-trial/ Fri, 25 Nov 2022 15:46:23 +0000 https://www.clinicaltrialsarena.com/?p=168659 The University of Queensland (UQ) has announced plans to advance a molecular clamp vaccine into a Phase I trial for future disease outbreaks.

The post University of Queensland to begin trial of molecular clamp vaccine appeared first on Clinical Trials Arena.

]]> The post University of Queensland to begin trial of molecular clamp vaccine appeared first on Clinical Trials Arena.

]]> Argenica announces first subject dosing in third cohort of ARG-007 trial https://www.clinicaltrialsarena.com/news/argenica-subjects-dosing-third-cohort/ Fri, 25 Nov 2022 15:33:31 +0000 https://www.clinicaltrialsarena.com/?p=168666 Argenica Therapeutics has announced the dosing of the first subjects in the third cohort of its Phase I clinical trial of ARG-007.

The post Argenica announces first subject dosing in third cohort of ARG-007 trial appeared first on Clinical Trials Arena.

]]> The post Argenica announces first subject dosing in third cohort of ARG-007 trial appeared first on Clinical Trials Arena.

]]> New Zealand MEDSAFE grants approval for Invex’s IIH therapy trial https://www.clinicaltrialsarena.com/news/new-zealand-invex-iih-trial/ Fri, 25 Nov 2022 12:07:12 +0000 https://www.clinicaltrialsarena.com/?p=168647 The New Zealand MEDSAFE granted approval to begin Invex Therapeutics' Phase III trial of Presendin for idiopathic intracranial hypertension.

The post New Zealand MEDSAFE grants approval for Invex’s IIH therapy trial appeared first on Clinical Trials Arena.

]]> The post New Zealand MEDSAFE grants approval for Invex’s IIH therapy trial appeared first on Clinical Trials Arena.

]]> University of Manchester opens precision medicine trial for rare cancers https://www.clinicaltrialsarena.com/news/university-of-manchester-precision/ Thu, 24 Nov 2022 15:18:29 +0000 https://www.clinicaltrialsarena.com/?p=168621 The University of Manchester, Cancer Research UK, and Roche Products have announced the start of a precision medicine trial for rare cancers.

The post University of Manchester opens precision medicine trial for rare cancers appeared first on Clinical Trials Arena.

]]> The post University of Manchester opens precision medicine trial for rare cancers appeared first on Clinical Trials Arena.

]]> Blockchain in clinical trial supply chains: more hype than heft? https://www.clinicaltrialsarena.com/features/blockchain-clinical-trial-supply-chains/ Mon, 07 Nov 2022 13:17:58 +0000 https://www.clinicaltrialsarena.com/?p=167846 Blockchain has been billed as a transformative technology to improve drug supply chain traceability, but many industry experts are skeptical.

The post Blockchain in clinical trial supply chains: more hype than heft? appeared first on Clinical Trials Arena.

]]> The post Blockchain in clinical trial supply chains: more hype than heft? appeared first on Clinical Trials Arena.

]]> Sites on wheels: bringing the clinical trial to the patient’s doorstep https://www.clinicaltrialsarena.com/features/sites-on-wheels-bringing-clinical-trial-to-patients/ Tue, 04 Oct 2022 08:45:15 +0000 https://www.clinicaltrialsarena.com/?p=166362 Clinical Trials Arena discusses with experts how study teams and sites can hit the road as another approach to decentralisation.

The post Sites on wheels: bringing the clinical trial to the patient’s doorstep appeared first on Clinical Trials Arena.

]]> The post Sites on wheels: bringing the clinical trial to the patient’s doorstep appeared first on Clinical Trials Arena.

]]> Can AI remedy the growing pains of digital biomarker development? https://www.clinicaltrialsarena.com/features/ai-and-digital-biomarker-development/ Mon, 15 Aug 2022 07:58:27 +0000 https://www.clinicaltrialsarena.com/?p=164254 AI implementation could be a useful tool to analyse generated data. Yet, digital biomarker regulatory approval hurdles are in sight.

The post Can AI remedy the growing pains of digital biomarker development? appeared first on Clinical Trials Arena.

]]> The post Can AI remedy the growing pains of digital biomarker development? appeared first on Clinical Trials Arena.

]]> Back to the future: the evolution of clinical conference topics in the past decade https://www.clinicaltrialsarena.com/features/arena-conference-trends/ Wed, 10 Aug 2022 14:43:40 +0000 https://www.clinicaltrialsarena.com/?p=164055 With the 20th birthday of the renowned Clinical Trial Supply East Coast conference in October, we look at topic changes in the past decade.

The post Back to the future: the evolution of clinical conference topics in the past decade appeared first on Clinical Trials Arena.

]]> The post Back to the future: the evolution of clinical conference topics in the past decade appeared first on Clinical Trials Arena.

]]>